Wednesday, February 4, 2026

Enterprise Viewpoint

834 POSTS

MEI Pharma to Host Investor and Analyst Video Webcast

MEI Pharma, Inc., a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it will host an investor and analyst...

Continuation of Partial Clinical Hold of Gemcabene From NeuroBo

NeuroBo Pharmaceuticals, Inc. a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced that...

Modernizing Pharmaceutical R&D

Apart from continually reassessing strategic directions and moving with deliberate speed, pharma players are increasingly seeking to innovate their R&D services to stay ahead...

Taking Pharma to the Cloud

Heal the world. Save lives. These crucial “vows” that one makes to the universe often lie in the source of medical innovation. Pharma industry...

Future of technical foam market

The global technical foam market size is estimated to be USD 9.1 billion in 2020 and is projected to reach USD 15.7 billion by...

CSCEC creeps to first again in brand value

May 10 was the fourth China Brand Day. China Council for Brand Development, China Appraisal Society, and other co-organizers jointly held the virtual 2020...

Ampio Provides Update on COVID-19 Program

 Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) is a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions. As part of this program, the...

Octo- Driving into a Safer Future

Last few years have been extremely critical for technology & telematics trade. We are well into the transformation phase which everyone has been preparing...

B2Gold Reports Strong Q1 2020 Results

VANCOUVER, May 5, 2020 /PRNewswire/ -B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) ("B2Gold" or the "Company") is pleased to announce its operational and...

eDriving- Making your Path Safe

Insurance technology structured around custom user-behaviour is no-doubt the next chapter for insurance sector. The possibility of curbing the risk by making decisions entirely...

Latest news